Skip to the content

KD&A - Regulatory Consultants for Medical and IVD devices

kdent@kdas.com.au
logo mainlogo darklogo light
  • About Us
    • About Us
    • What our Clients Say
    • Frequently Asked Questions
  • Our Services
    • Medical Device Regulatory Strategy
    • ISO 13485 & MDSAP QMS Creation and Maintenance | KD&A Expert Regulatory Support
    • Internal Auditing & Audit Support (ISO 13485) | KD&A Expert Regulatory Support
    • Technical File Documentation | KD&A Expert Regulatory Support
    • Global Medical Device Registrations & ARTG Inclusions | KD&A Expert Regulatory Support
    • Post Market Surveillance (PMS) | KD&A Expert Regulatory Support
    • TGA Conformity Assessment and CE Marking | KD&A Expert Regulatory Support
    • Promotional Materials Review | KD&A Expert Regulatory Support
    • Australian TGA Sponsor Services | KD&A Expert Regulatory Support
    • Medical Device & IVD Classification Assessment | KD&A Expert Regulatory Support
    • Software as a Medical Device | KD&A Expert Regulatory Support
    • Retainer Services | KD&A Expert Regulatory Support
  • Our Clients
    • Australian Sponsors & Distributors | KD&A Expert Regulatory Support
    • Medical Device Manufacturers | KD&A Expert Regulatory Support
    • International Medical Device Manufacturers | KD&A Expert Regulatory Solutions
    • Our Clients
  • News
  • Useful Links
Get In Touch
logo main
  • About Us
    • What our Clients Say
    • Frequently Asked Questions
    • Useful Links
  • Our Services
    • Medical Device Regulatory Strategy
    • ISO 13485 & MDSAP QMS Creation and Maintenance | KD&A Expert Regulatory Support
    • Internal Auditing & Audit Support (ISO 13485) | KD&A Expert Regulatory Support
    • Technical File Documentation | KD&A Expert Regulatory Support
    • Global Medical Device Registrations & ARTG Inclusions | KD&A Expert Regulatory Support
    • Post Market Surveillance (PMS) | KD&A Expert Regulatory Support
    • TGA Conformity Assessment and CE Marking | KD&A Expert Regulatory Support
    • Promotional Materials Review | KD&A Expert Regulatory Support
    • Australian TGA Sponsor Services | KD&A Expert Regulatory Support
    • Medical Device & IVD Classification Assessment | KD&A Expert Regulatory Support
    • Software as a Medical Device | KD&A Expert Regulatory Support
    • Retainer Services | KD&A Expert Regulatory Support
  • Our Clients
    • Australian Sponsors & Distributors | KD&A Expert Regulatory Support
    • Medical Device Manufacturers | KD&A Expert Regulatory Support
    • International Medical Device Manufacturers | KD&A Expert Regulatory Solutions
  • Latest News
  • Contact Us

Medicinal Substances Tag

06
Dec
Regulatory ChangesResearchTGA

KD&A Can Help You From the Start – Medical Devices Steps to Market

Do you have a medical device and don’t know what to do? Medical devices include a wide range of products from bandages to heart valves and in most regions, the term medical devic

Read More
Share
01
Sep
Regulatory ChangesResearchTGA

New Regulatory Changes for Medical Devices Containing Medicinal Substances, Animal, Microbial, or Recombinant Materials

As of 1 July 2024, new regulatory requirements for medical devices containing medicinal substances, or materials derived from animal, microbial, or recombinant sources will take ef

Read More
Share
16
Sep
Regulatory ChangesResearchTGA

Important Changes in the Regulatory Framework for IVDs

Goods new for laboratories that manufacture Class 4 in-house IVDs. A new conformity assessment procedure has been introduced.

Read More
Share
09
Dec
Regulatory ChangesResearchTGA

Therapeutic Goods Administration (TGA) Introduce Online Medical Device Incident Reporting (MDIR) System

The TGA have introduced a new online MDIR System for sponsors and manufacturers which is accessible via their eBusiness system (also used to submit applications). The eBusiness sys

Read More
Share
21
Nov
Regulatory ChangesResearchTGA

Medical Device Single Audit Program (MDSAP)

The International Medical Device Regulators Forum (IMDRF) began work on developing documentation to facilitate the Medical Device Single Audit Program (MDSAP) in Singapore in 2012.

Read More
Share
29
Aug
Regulatory ChangesResearchTGA

TGA Medical Device Reforms – Product Names Requirement Cancelled

The TGA have announced that a component of the medical device reforms outlined in the TGA blueprint will not go ahead. The initiative to record all devices included under a device

Read More
Share
29
Aug
Regulatory ChangesResearchTGA

NZ Medical Device Recalls Remind Medical Device Suppliers to be Prepared

New Zealand (NZ)’s regulatory body for therapeutic goods, Medsafe, have issued a reminder to medical device suppliers to ensure they are suitability prepared for a recall should

Read More
Share
18
Jul
Regulatory ChangesResearchTGA

Hip, Knee and Shoulder Joint Reclassification: Only 12 Months Remain

The TGA are working towards the deadline of 30 July 2014 to finalise the reclassification of total or partial hip, knee and should joints. In another step towards this deadline, th

Read More
Share
03
Jul
Regulatory ChangesResearchTGA

Information Feature: TGA Application Audit

As of 1 July 2024, new regulatory requirements for medical devices containing medicinal substances, or materials derived from animal, microbial, or recombinant sources will take ef

Read More
Share
17
Jun
Regulatory ChangesResearchTGA

Workshop – Key Topic Information

As of 1 July 2024, new regulatory requirements for medical devices containing medicinal substances, or materials derived from animal, microbial, or recombinant sources will take ef

Read More
Share

Posts pagination

01 02
News Categories
  • EU
  • FDA
  • International Standards
  • KD&A
  • Medical Device Classification
  • Regulatory Changes
  • Research
  • Software
  • Technology
  • TGA
  • UK
Latest Articles
July 21, 2026
ISO 20417:2026 Has Been Published: What Medical Manufacturers Need to Know
June 25, 2026
Understanding Australia’s Consent to Supply Mechanism for Medical Devices
May 19, 2026
TGA Now Accepting UK Conformity Assessed (UKCA) Certification as Comparable Overseas Evidence: What This Means for Medical Device Sponsors
April 23, 2026
From Voluntary to Mandatory: The Evolution of Post-Market Surveillance in Australia
Tags

Australia Australian Medical Device Regulatory Framework European Union Manufacturer's Evidence Medical Device Medical Device Regulations Medicinal Substances Regulatory Changes Regulatory Compliance Regulatory Requirements Regulatory Strategy TGA

  • What We Do
  • Who We Help
  • What our Clients Say
+ 61 411 101 392
kdent@kdas.com.au

Get our latest expert updates to your inbox

KD&A provides expert regulatory consulting service to medical device and IVD companies selling on Australian and International markets.

    Contact us:
    kdent@kdas.com.au
    +61 411 101 392
    Our address:
    Suite 13,
    67 Wanganella Street,
    Balgowlah NSW 2093, Australia
    Our social:
    Terms and conditions
    Privacy policy
    © 2025 KD&A Pty Ltd
    w

    Lorem ipsum dolor sit amet, consectetur adipiscing elit eiusmod tempor

    w
    leroux@qodeinteractive.com